Request for Covid-19 Impact Assessment of this Report
The United States Hepatitis B Immune Globulin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hepatitis B Immune Globulin market, reaching US$ million by the year 2028. As for the Europe Hepatitis B Immune Globulin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Hepatitis B Immune Globulin players cover ADMA Biologics, Bio Products Laboratory, Grifols, and Biotest AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hepatitis B Immune Globulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Intravenous Injection
Intramuscular Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Liver Transplant Patients
Newborn Baby
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ADMA Biologics
Bio Products Laboratory
Grifols
Biotest AG
CSL Behring
FFF Enterprises
Cleveland Clinic
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis B Immune Globulin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hepatitis B Immune Globulin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hepatitis B Immune Globulin by Country/Region, 2017, 2022 & 2028
2.2 Hepatitis B Immune Globulin Segment by Type
2.2.1 Intravenous Injection
2.2.2 Intramuscular Injection
2.3 Hepatitis B Immune Globulin Sales by Type
2.3.1 Global Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
2.3.2 Global Hepatitis B Immune Globulin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hepatitis B Immune Globulin Sale Price by Type (2017-2022)
2.4 Hepatitis B Immune Globulin Segment by Application
2.4.1 Liver Transplant Patients
2.4.2 Newborn Baby
2.4.3 Others
2.5 Hepatitis B Immune Globulin Sales by Application
2.5.1 Global Hepatitis B Immune Globulin Sale Market Share by Application (2017-2022)
2.5.2 Global Hepatitis B Immune Globulin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hepatitis B Immune Globulin Sale Price by Application (2017-2022)
3 Global Hepatitis B Immune Globulin by Company
3.1 Global Hepatitis B Immune Globulin Breakdown Data by Company
3.1.1 Global Hepatitis B Immune Globulin Annual Sales by Company (2020-2022)
3.1.2 Global Hepatitis B Immune Globulin Sales Market Share by Company (2020-2022)
3.2 Global Hepatitis B Immune Globulin Annual Revenue by Company (2020-2022)
3.2.1 Global Hepatitis B Immune Globulin Revenue by Company (2020-2022)
3.2.2 Global Hepatitis B Immune Globulin Revenue Market Share by Company (2020-2022)
3.3 Global Hepatitis B Immune Globulin Sale Price by Company
3.4 Key Manufacturers Hepatitis B Immune Globulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hepatitis B Immune Globulin Product Location Distribution
3.4.2 Players Hepatitis B Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hepatitis B Immune Globulin by Geographic Region
4.1 World Historic Hepatitis B Immune Globulin Market Size by Geographic Region (2017-2022)
4.1.1 Global Hepatitis B Immune Globulin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hepatitis B Immune Globulin Annual Revenue by Geographic Region
4.2 World Historic Hepatitis B Immune Globulin Market Size by Country/Region (2017-2022)
4.2.1 Global Hepatitis B Immune Globulin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hepatitis B Immune Globulin Annual Revenue by Country/Region
4.3 Americas Hepatitis B Immune Globulin Sales Growth
4.4 APAC Hepatitis B Immune Globulin Sales Growth
4.5 Europe Hepatitis B Immune Globulin Sales Growth
4.6 Middle East & Africa Hepatitis B Immune Globulin Sales Growth
5 Americas
5.1 Americas Hepatitis B Immune Globulin Sales by Country
5.1.1 Americas Hepatitis B Immune Globulin Sales by Country (2017-2022)
5.1.2 Americas Hepatitis B Immune Globulin Revenue by Country (2017-2022)
5.2 Americas Hepatitis B Immune Globulin Sales by Type
5.3 Americas Hepatitis B Immune Globulin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hepatitis B Immune Globulin Sales by Region
6.1.1 APAC Hepatitis B Immune Globulin Sales by Region (2017-2022)
6.1.2 APAC Hepatitis B Immune Globulin Revenue by Region (2017-2022)
6.2 APAC Hepatitis B Immune Globulin Sales by Type
6.3 APAC Hepatitis B Immune Globulin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hepatitis B Immune Globulin by Country
7.1.1 Europe Hepatitis B Immune Globulin Sales by Country (2017-2022)
7.1.2 Europe Hepatitis B Immune Globulin Revenue by Country (2017-2022)
7.2 Europe Hepatitis B Immune Globulin Sales by Type
7.3 Europe Hepatitis B Immune Globulin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hepatitis B Immune Globulin by Country
8.1.1 Middle East & Africa Hepatitis B Immune Globulin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hepatitis B Immune Globulin Revenue by Country (2017-2022)
8.2 Middle East & Africa Hepatitis B Immune Globulin Sales by Type
8.3 Middle East & Africa Hepatitis B Immune Globulin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hepatitis B Immune Globulin
10.3 Manufacturing Process Analysis of Hepatitis B Immune Globulin
10.4 Industry Chain Structure of Hepatitis B Immune Globulin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hepatitis B Immune Globulin Distributors
11.3 Hepatitis B Immune Globulin Customer
12 World Forecast Review for Hepatitis B Immune Globulin by Geographic Region
12.1 Global Hepatitis B Immune Globulin Market Size Forecast by Region
12.1.1 Global Hepatitis B Immune Globulin Forecast by Region (2023-2028)
12.1.2 Global Hepatitis B Immune Globulin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hepatitis B Immune Globulin Forecast by Type
12.7 Global Hepatitis B Immune Globulin Forecast by Application
13 Key Players Analysis
13.1 ADMA Biologics
13.1.1 ADMA Biologics Company Information
13.1.2 ADMA Biologics Hepatitis B Immune Globulin Product Offered
13.1.3 ADMA Biologics Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ADMA Biologics Main Business Overview
13.1.5 ADMA Biologics Latest Developments
13.2 Bio Products Laboratory
13.2.1 Bio Products Laboratory Company Information
13.2.2 Bio Products Laboratory Hepatitis B Immune Globulin Product Offered
13.2.3 Bio Products Laboratory Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Bio Products Laboratory Main Business Overview
13.2.5 Bio Products Laboratory Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Hepatitis B Immune Globulin Product Offered
13.3.3 Grifols Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Biotest AG
13.4.1 Biotest AG Company Information
13.4.2 Biotest AG Hepatitis B Immune Globulin Product Offered
13.4.3 Biotest AG Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biotest AG Main Business Overview
13.4.5 Biotest AG Latest Developments
13.5 CSL Behring
13.5.1 CSL Behring Company Information
13.5.2 CSL Behring Hepatitis B Immune Globulin Product Offered
13.5.3 CSL Behring Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 CSL Behring Main Business Overview
13.5.5 CSL Behring Latest Developments
13.6 FFF Enterprises
13.6.1 FFF Enterprises Company Information
13.6.2 FFF Enterprises Hepatitis B Immune Globulin Product Offered
13.6.3 FFF Enterprises Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 FFF Enterprises Main Business Overview
13.6.5 FFF Enterprises Latest Developments
13.7 Cleveland Clinic
13.7.1 Cleveland Clinic Company Information
13.7.2 Cleveland Clinic Hepatitis B Immune Globulin Product Offered
13.7.3 Cleveland Clinic Hepatitis B Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Cleveland Clinic Main Business Overview
13.7.5 Cleveland Clinic Latest Developments
14 Research Findings and Conclusion
Table 1. Hepatitis B Immune Globulin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Hepatitis B Immune Globulin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Intravenous Injection
Table 4. Major Players of Intramuscular Injection
Table 5. Global Hepatitis B Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 6. Global Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
Table 7. Global Hepatitis B Immune Globulin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Hepatitis B Immune Globulin Revenue Market Share by Type (2017-2022)
Table 9. Global Hepatitis B Immune Globulin Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Hepatitis B Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 11. Global Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
Table 12. Global Hepatitis B Immune Globulin Revenue by Application (2017-2022)
Table 13. Global Hepatitis B Immune Globulin Revenue Market Share by Application (2017-2022)
Table 14. Global Hepatitis B Immune Globulin Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Hepatitis B Immune Globulin Sales by Company (2020-2022) & (K Units)
Table 16. Global Hepatitis B Immune Globulin Sales Market Share by Company (2020-2022)
Table 17. Global Hepatitis B Immune Globulin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Hepatitis B Immune Globulin Revenue Market Share by Company (2020-2022)
Table 19. Global Hepatitis B Immune Globulin Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Hepatitis B Immune Globulin Producing Area Distribution and Sales Area
Table 21. Players Hepatitis B Immune Globulin Products Offered
Table 22. Hepatitis B Immune Globulin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Hepatitis B Immune Globulin Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Hepatitis B Immune Globulin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Hepatitis B Immune Globulin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Hepatitis B Immune Globulin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Hepatitis B Immune Globulin Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Hepatitis B Immune Globulin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Hepatitis B Immune Globulin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Hepatitis B Immune Globulin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Hepatitis B Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 34. Americas Hepatitis B Immune Globulin Sales Market Share by Country (2017-2022)
Table 35. Americas Hepatitis B Immune Globulin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Hepatitis B Immune Globulin Revenue Market Share by Country (2017-2022)
Table 37. Americas Hepatitis B Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 38. Americas Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
Table 39. Americas Hepatitis B Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 40. Americas Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
Table 41. APAC Hepatitis B Immune Globulin Sales by Region (2017-2022) & (K Units)
Table 42. APAC Hepatitis B Immune Globulin Sales Market Share by Region (2017-2022)
Table 43. APAC Hepatitis B Immune Globulin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Hepatitis B Immune Globulin Revenue Market Share by Region (2017-2022)
Table 45. APAC Hepatitis B Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 46. APAC Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
Table 47. APAC Hepatitis B Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 48. APAC Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
Table 49. Europe Hepatitis B Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 50. Europe Hepatitis B Immune Globulin Sales Market Share by Country (2017-2022)
Table 51. Europe Hepatitis B Immune Globulin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Hepatitis B Immune Globulin Revenue Market Share by Country (2017-2022)
Table 53. Europe Hepatitis B Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 54. Europe Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
Table 55. Europe Hepatitis B Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 56. Europe Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Hepatitis B Immune Globulin Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Hepatitis B Immune Globulin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Hepatitis B Immune Globulin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Hepatitis B Immune Globulin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Hepatitis B Immune Globulin Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Hepatitis B Immune Globulin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Hepatitis B Immune Globulin Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Hepatitis B Immune Globulin
Table 66. Key Market Challenges & Risks of Hepatitis B Immune Globulin
Table 67. Key Industry Trends of Hepatitis B Immune Globulin
Table 68. Hepatitis B Immune Globulin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Hepatitis B Immune Globulin Distributors List
Table 71. Hepatitis B Immune Globulin Customer List
Table 72. Global Hepatitis B Immune Globulin Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Hepatitis B Immune Globulin Sales Market Forecast by Region
Table 74. Global Hepatitis B Immune Globulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Hepatitis B Immune Globulin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Hepatitis B Immune Globulin Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Hepatitis B Immune Globulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Hepatitis B Immune Globulin Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Hepatitis B Immune Globulin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Hepatitis B Immune Globulin Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Hepatitis B Immune Globulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Hepatitis B Immune Globulin Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Hepatitis B Immune Globulin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Hepatitis B Immune Globulin Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Hepatitis B Immune Globulin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Hepatitis B Immune Globulin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Hepatitis B Immune Globulin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Hepatitis B Immune Globulin Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Hepatitis B Immune Globulin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Hepatitis B Immune Globulin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Hepatitis B Immune Globulin Revenue Market Share Forecast by Application (2023-2028)
Table 92. ADMA Biologics Basic Information, Hepatitis B Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 93. ADMA Biologics Hepatitis B Immune Globulin Product Offered
Table 94. ADMA Biologics Hepatitis B Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. ADMA Biologics Main Business
Table 96. ADMA Biologics Latest Developments
Table 97. Bio Products Laboratory Basic Information, Hepatitis B Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 98. Bio Products Laboratory Hepatitis B Immune Globulin Product Offered
Table 99. Bio Products Laboratory Hepatitis B Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Bio Products Laboratory Main Business
Table 101. Bio Products Laboratory Latest Developments
Table 102. Grifols Basic Information, Hepatitis B Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 103. Grifols Hepatitis B Immune Globulin Product Offered
Table 104. Grifols Hepatitis B Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Grifols Main Business
Table 106. Grifols Latest Developments
Table 107. Biotest AG Basic Information, Hepatitis B Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 108. Biotest AG Hepatitis B Immune Globulin Product Offered
Table 109. Biotest AG Hepatitis B Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Biotest AG Main Business
Table 111. Biotest AG Latest Developments
Table 112. CSL Behring Basic Information, Hepatitis B Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 113. CSL Behring Hepatitis B Immune Globulin Product Offered
Table 114. CSL Behring Hepatitis B Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. CSL Behring Main Business
Table 116. CSL Behring Latest Developments
Table 117. FFF Enterprises Basic Information, Hepatitis B Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 118. FFF Enterprises Hepatitis B Immune Globulin Product Offered
Table 119. FFF Enterprises Hepatitis B Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. FFF Enterprises Main Business
Table 121. FFF Enterprises Latest Developments
Table 122. Cleveland Clinic Basic Information, Hepatitis B Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 123. Cleveland Clinic Hepatitis B Immune Globulin Product Offered
Table 124. Cleveland Clinic Hepatitis B Immune Globulin Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Cleveland Clinic Main Business
Table 126. Cleveland Clinic Latest Developments
List of Figures
Figure 1. Picture of Hepatitis B Immune Globulin
Figure 2. Hepatitis B Immune Globulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Hepatitis B Immune Globulin Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Hepatitis B Immune Globulin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Hepatitis B Immune Globulin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Intravenous Injection
Figure 10. Product Picture of Intramuscular Injection
Figure 11. Global Hepatitis B Immune Globulin Sales Market Share by Type in 2021
Figure 12. Global Hepatitis B Immune Globulin Revenue Market Share by Type (2017-2022)
Figure 13. Hepatitis B Immune Globulin Consumed in Liver Transplant Patients
Figure 14. Global Hepatitis B Immune Globulin Market: Liver Transplant Patients (2017-2022) & (K Units)
Figure 15. Hepatitis B Immune Globulin Consumed in Newborn Baby
Figure 16. Global Hepatitis B Immune Globulin Market: Newborn Baby (2017-2022) & (K Units)
Figure 17. Hepatitis B Immune Globulin Consumed in Others
Figure 18. Global Hepatitis B Immune Globulin Market: Others (2017-2022) & (K Units)
Figure 19. Global Hepatitis B Immune Globulin Sales Market Share by Application (2017-2022)
Figure 20. Global Hepatitis B Immune Globulin Revenue Market Share by Application in 2021
Figure 21. Hepatitis B Immune Globulin Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Hepatitis B Immune Globulin Revenue Market Share by Company in 2021
Figure 23. Global Hepatitis B Immune Globulin Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Hepatitis B Immune Globulin Revenue Market Share by Geographic Region in 2021
Figure 25. Global Hepatitis B Immune Globulin Sales Market Share by Region (2017-2022)
Figure 26. Global Hepatitis B Immune Globulin Revenue Market Share by Country/Region in 2021
Figure 27. Americas Hepatitis B Immune Globulin Sales 2017-2022 (K Units)
Figure 28. Americas Hepatitis B Immune Globulin Revenue 2017-2022 ($ Millions)
Figure 29. APAC Hepatitis B Immune Globulin Sales 2017-2022 (K Units)
Figure 30. APAC Hepatitis B Immune Globulin Revenue 2017-2022 ($ Millions)
Figure 31. Europe Hepatitis B Immune Globulin Sales 2017-2022 (K Units)
Figure 32. Europe Hepatitis B Immune Globulin Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Hepatitis B Immune Globulin Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Hepatitis B Immune Globulin Revenue 2017-2022 ($ Millions)
Figure 35. Americas Hepatitis B Immune Globulin Sales Market Share by Country in 2021
Figure 36. Americas Hepatitis B Immune Globulin Revenue Market Share by Country in 2021
Figure 37. United States Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Hepatitis B Immune Globulin Sales Market Share by Region in 2021
Figure 42. APAC Hepatitis B Immune Globulin Revenue Market Share by Regions in 2021
Figure 43. China Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Hepatitis B Immune Globulin Sales Market Share by Country in 2021
Figure 50. Europe Hepatitis B Immune Globulin Revenue Market Share by Country in 2021
Figure 51. Germany Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Hepatitis B Immune Globulin Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Hepatitis B Immune Globulin Revenue Market Share by Country in 2021
Figure 58. Egypt Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Hepatitis B Immune Globulin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Hepatitis B Immune Globulin in 2021
Figure 64. Manufacturing Process Analysis of Hepatitis B Immune Globulin
Figure 65. Industry Chain Structure of Hepatitis B Immune Globulin
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...